Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Germ Cell Tumors

Gedske Daugaard

格茨克·道加德

MD, DMSc

🏢Copenhagen University Hospital (Rigshospitalet)(哥本哈根大学医院(国立医院))🌐Denmark

Professor and Head, Department of Oncology; Danish GCT Reference Center Director肿瘤科主任教授;丹麦生殖细胞肿瘤参考中心主任

48
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Leading Nordic authority on testicular GCT and director of the Danish National GCT Reference Center. Internationally recognized for landmark surveillance studies, population-based epidemiology, and Nordic collaborative research that have shaped global GCT management guidelines.

Share:

🧪Research Fields 研究领域

Germ Cell Tumors生殖细胞肿瘤
Testicular Cancer睾丸癌
Surveillance Protocols监测方案

🎓Key Contributions 主要贡献

Active Surveillance Protocols for GCT

Established evidence-based surveillance schedules for stage I testicular cancer through large Danish cohort studies, demonstrating safety of omitting adjuvant therapy with rigorous monitoring.

Nordic GCT Collaboration (SWENOTECA)

Led SWENOTECA consortium producing population-based prospective GCT outcome data, enabling refined risk-adapted treatment recommendations adopted across Scandinavia and Europe.

GCT Epidemiology and Biomarkers

Conducted comprehensive population-based studies on GCT incidence trends, risk factors, and serum biomarker validation including miR-371a-3p in Nordic populations.

Representative Works 代表性著作

[1]

Active Surveillance Following Orchidectomy for Stage I Nonseminomatous Germ Cell Tumors

Journal of Clinical Oncology (2014)

Large Danish cohort demonstrating >99% cause-specific survival with surveillance in stage I NSGCT, supporting active surveillance as preferred management.

[2]

SWENOTECA: Risk-Adapted Treatment for Stage I Seminoma

Annals of Oncology (2015)

Population-based prospective data on risk-adapted surveillance vs. carboplatin for stage I seminoma across Nordic countries.

[3]

Serum microRNA-371a-3p in the Diagnosis of Germ Cell Tumors

European Urology (2020)

Validated miR-371a-3p as a sensitive marker for active GCT in a large multicenter Nordic cohort, supporting clinical implementation.

🏆Awards & Recognition 奖项与荣誉

🏆Danish Cancer Society Research Prize
🏆Nordic Association of Urology Distinguished Lecturer
🏆ESMO Fellowship Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 格茨克·道加德 的研究动态

Follow Gedske Daugaard's research updates

留下邮箱,当我们发布与 Gedske Daugaard(Copenhagen University Hospital (Rigshospitalet))相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment